SciVision Biotech Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 206.1 million compared to TWD 164.9 million a year ago. Net income was TWD 54.6 million compared to TWD 45.54 million a year ago. Basic earnings per share from continuing operations was TWD 0.81 compared to TWD 0.69 a year ago. Diluted earnings per share from continuing operations was TWD 0.76 compared to TWD 0.69 a year ago.
For the nine months, sales was TWD 509.74 million compared to TWD 397.48 million a year ago. Net income was TWD 138.57 million compared to TWD 112.17 million a year ago. Basic earnings per share from continuing operations was TWD 2.08 compared to TWD 1.69 a year ago. Diluted earnings per share from continuing operations was TWD 1.92 compared to TWD 1.69 a year ago.